register

Medical

Aussie researchers receive $2.9m funding boost for multiple sclerosis

Health Industry Hub | January 22, 2021 |
[Total: 1    Average: 5/5]

Medical News: Twenty multiple sclerosis (MS) scientific research teams across the country will receive an important New Year funding injection this week with MS Research Australia/MS Australia announcing a major $2.9M grants program that will ensure critical research projects get underway to uncover new ways to investigate, manage and treat MS.

The substantial grant program is thanks to the record-breaking fundraising efforts of Australia’s MS community which last year went against a significant overall decline in charitable donations from COVID-19. Despite the start of the pandemic and lock-down around the country, MS Research Australia’s fundraising initiative – The May 50K – saw 26,500 participants run and walk 50km in the month of May for MS.

Newly appointed CEO of MS Australia, Rohan Greenland says; “Maintaining momentum in MS research in this country is our absolute priority, so we are extremely proud to be announcing the recipients of our Investigator led grants program today. These researchers are incredibly talented, and it is our priority to help our research community keep their labs open and continue their world class research so we can stop and reverse the effects of MS.”

“Since inception MS Research Australia has invested over $47 million into MS research, supporting 10 major collaborative platforms and 327 investigator led projects like the ones we are announcing today. This would not happen without our amazing MS community and the outstanding example they set in raising funds to directly support Australian research. We thank each and every one for their ongoing energy and support,” he adds.

The $2.9 million grants program will be provided to 20 new projects recognised by MS Research Australia/MS Australia as important priorities requiring funding. The initiatives include investigations into the causes and prevention of MS, better treatments via repair and regeneration of cells, and more effective monitoring of disease activity.

Around 90% of researchers believe there are going to be delays in research milestones as a result of COVID-191, so the provision of local MS research grants has been welcomed by the research community – including grant recipient and one of Australia’s leading researchers Professor Rodney Scott from the Hunter Medical Research Institute in NSW. Professor Scott is aiming to develop a biomarker test to track disease activity in MS patients.

You may also like Changing MSL value proposition accelerated by the COVID-19 pandemic

“MS is a complex disease which is often difficult to diagnose and challenging to manage. We therefore hope our investigations can lead to improved monitoring of disease activity which will minimise irreversible damage to patients’ brains and spinal cords,” says Professor Scott.

“Our work is dependent on funding from research bodies like MS Research Australia and ultimately the generosity of donors, so we are incredibly thankful to the MS community for ensuring our research project can happen, particularly in such challenging times,” he adds.

Dr Vivienne Guan from the University of Wollongong has been awarded a post-doctoral fellowship which will be allowing her team to develop and evaluate a mobile phone app to support people living with MS to self-manage food choices in line with current Australian dietary guidelines. For people living with MS, this may relieve some of the cognitive stress associated with planning and co-ordinating food choices on a daily basis.

Dr Guan says, “I am so grateful to MS Research Australia for this funding. We believe it’s extremely important to keep our research efforts going even during these difficult times. The fact the MS community acknowledges the importance of our research makes this grant even more special to us.”
Research Recipients

For a full list of all 20 grant recipients please visit the MS Research Australia website.


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

Medical

Medical Pharma Biotech MedTech - Clinical changes to cervical cancer screening program

Clinical changes to cervical cancer screening program

Health Industry Hub | March 5, 2021 |

Medical News: Changes to the National Cervical Screening Program (NCSP) Guidelines for the clinical management of women at intermediate risk […]

More


News & Trends - Medical Technology

MedTech News - Philips partners for world-first research to reduce patient anxiety during MRI scans

Philips partners for world-first research to reduce patient anxiety during MRI scans

Health Industry Hub | March 5, 2021 |

MedTech News: Philips, a global leader in health technology, is teaming up to test the effects of custom-made animation within […]

More


News & Trends - Pharmaceuticals

Pharma News - Merck marks International Women’s Day with commitment to gender equality and APEC research prize

Merck marks International Women’s Day with commitment to gender equality and APEC research prize

Health Industry Hub | March 5, 2021 |

Pharma News: Merck, a leading science and technology company, is marking International Women’s Day (8 March) with a range of […]

More


News & Trends - Medical Technology

MedTech News - Health insurers holding $1.8 billion excess funds from deferred claims

Health insurers holding $1.8 billion excess funds from deferred claims

Health Industry Hub | March 5, 2021 |

MedTech News: The Australian Private Hospitals Association (APHA) has welcomed the move by private health insurer HBF to repay members […]

More